Emerging Concepts in the Recognition and Management of Systemic Lupus Erythematosus

Released On
January 31, 2019

Expires On
January 30, 2020

Media Type
Internet

Completion Time
120 minutes

Specialty
Rheumatology

Topic(s)
Lupus

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Annenberg Center for Health Sciences at Eisenhower.


Supported by an educational grant from GlaxoSmithKline.

Credit Available

  • Physicians — maximum of 2.0 AMA PRA Category 1 Credit(s)
  • Nurse Practitioners — 2.0 contact hours.
  • Nurses — 2.0 contact hours.

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for rheumatologists, family physicians, internal medicine physicians, nurse practitioners, nurses, physician assistants and other physicians who manage patients with SLE.

Program Overview

Content Areas:

  • Signs and symptoms
  • Diagnosis
  • Organ-threatening disease
  • Non-organ-threatening disease
  • Treatment goals
  • Adherence and monitoring
  • Prognosis
  • Research topics
  • Clinical trials

Learning Objectives

Upon completion of this activity, participants should be able to:

Rheumatologists:

  • Develop SLE treatment plans based on individual patients' disease characteristics and treatment goals
  • Identify a validated SLE disease activity measure for regular patient monitoring
  • Incorporate recommendations for the use of existing and newly approved treatments for SLE into clinical practice

Primary Care Physicians:

  • Apply the ACR diagnostic criteria to recognize patients who may have SLE
  • Utilize and interpret laboratory findings to investigate possible SLE
  • Develop SLE treatment plans based on individual patients’ disease characteristics, treatment goals, and consensus recommendations
  • Identify a validated SLE disease activity measure for regular patient monitoring

Faculty

Daniel J. Wallace, MD, FACP, MACR

Associate Director, Rheumatology Fellowship Program
Board of Governors, Cedars-Sinai Medical Center
Professor of Medicine, Cedars-Sinai Medical Center
David Geffen School of Medicine Center at UCLA
In affiliation with Attune Health
Los Angeles, California

Michelle Petri, MD, MPH

Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland

Physician Continuing Medical Education

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Practitioner Continuing Education

Accreditation Statement

Annenberg Center for Health Sciences at Eisenhower is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.

Credit Designation

This program is accredited for 2.0 contact hours. Program ID #5635-EM.

Nursing Continuing Education

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designation

A maximum of 2.0 contact hours may be earned for successful completion of this activity.

Provider is approved by the California Board of Registered Nursing, Provider #13664, for 2.0 contact hours.

Disclosures of Conflicts of Interest

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:

Daniel J. Wallace, MD, FACP, MACR

  • Consultant: Amgen- clinical area: Lupus, EMD Serono- clinical area: Lupus, Lilly- clinical area: Lupus, Merck- clinical area: Lupus,

Michelle Petri, MD, MPH

  • Research Support: AstraZeneca- clinical area: Lupus, Exagen- clinical area: Lupus
  • Consultant: Amgen- clinical area: Lupus, Decision Resources- clinical area: Lupus, EMD Serono- clinical area: Lupus, GlaxoSmithKline- clinical area: Lupus, Inova Diagnostics- clinical area: Lupus, Janssen- clinical area: Lupus, Lilly- clinical area: Lupus, Merck- clinical area: Lupus, Novartis- clinical area: Lupus, Quintiles- clinical area: Lupus

The faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications.

Additional content planners

  • Chris Fisher (medical writer): no significant relationship to disclose
  • Coy Flowers, MD (peer reviewer): no significant relationship to disclose

Annenberg Center for Health Sciences

The staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use

The faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications.

Method of Participation

There are no fees to participate in the activity. Participants must review all activity information, including the learning objectives, disclosure statements, and content. To receive credit for participation, participants must complete the post-test (achieving a passing grade) and program evaluation. Certificates can be printed immediately.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.

Disclaimer

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.